Castanea sativa Mill. Extract contracts gallbladder and relaxes sphincter of oddi in Guinea Pig: A natural approach to biliary tract motility disorders

Journal of Medicinal Food

Volumn 17, Issue 7, 2014, Pages 795-803

  Micucci, Matteo ^a   Ioan, Pierfranco ^a   Aldini, Rita ^a   Cevenini, Monica ^a   Alvisi, Vittorio ^b   Ruffilli, Corrado ^c   Chiarini, Alberto ^a   Budriesi, Roberta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Nucleo di Cure Primarie 1   (Italy)

Author keywords

adrenergic receptors; calcium channels; cholecystokinin; cholesterol gallstones; cholinergic; gallbladder emptying; natural substances; non competitive mechanism

Indexed keywords

ADRENERGIC RECEPTOR; ATROPINE; CALCIUM CHANNEL; CARBACHOL; CASTANEA SATIVA EXTRACT; CHOLECYSTOKININ A RECEPTOR; CHOLESTEROL; CHOLINERGIC RECEPTOR; LINTITRIPT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N TERT BUTYLOXYCARBONYLTRYPTOPHYL[NEPSILON (2 METHYLPHENYLAMINOCARBONYL)LYSYL]ASPARTYL N METHYLPHENYLALANINAMIDE; NICARDIPINE; NITRENDIPINE; NORADRENALIN; PLANT EXTRACT; POTASSIUM CHLORIDE; PROPRANOLOL; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLESTEROL INTAKE; CHOLINERGIC RECEPTOR STIMULATING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADRENERGIC ACTIVITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTANEA SATIVA; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; GALLBLADDER CONTRACTION; GALLBLADDER DYSMOTILITY; GALLBLADDER MOTILITY; GALLSTONE; GUINEA PIG; HIGH RISK POPULATION; IC 50; INTESTINAL DYSMOTILITY; INTESTINE MOTILITY; MALE; NONHUMAN; ODDI SPHINCTER; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SPASMOLYSIS; ANIMAL; BILIARY TRACT DISEASES; BLOOD; CHEMISTRY; CHOLESTEROL INTAKE; DRUG EFFECTS; FAGACEAE; GALLBLADDER; GALLBLADDER EMPTYING; LIPID DIET; LIVER; METABOLISM; MUSCLE CONTRACTION;

ADRENERGIC AGENTS; ANIMALS; BILIARY TRACT DISEASES; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLINERGIC AGENTS; DIET, HIGH-FAT; FAGACEAE; GALLBLADDER; GALLBLADDER EMPTYING; GUINEA PIGS; LIVER; MALE; MUSCLE CONTRACTION; PLANT EXTRACTS; SPHINCTER OF ODDI; TRIGLYCERIDES;

EID: 84904340413     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2013.0090     Document Type: Article

References (41)

1. Budriesi R, Ioan P, Micucci M, et al.: Stop Fitan: Antispasmodic Effect of Natural Extract of Chestnut Wood in Guinea Pig Ileum and Proximal Colon Smooth Muscle. J Med Food 2010;5:1104-1110.
2. Chiarini A, Micucci M, Malaguti M, et al.: Sweet Chestnut (Castanea Sativa Mill.) bark extract: cardiovascular activity and myocyte protection against oxidative damage. Oxid Med Cell Longev, 2013;2013:471790.
3. Buzzini P, Arapitsas P, Goretti M, et al.: Antimicrobial and antiviral activity of hydrolysable tannins. Mini Rev Med Chem 2008;8:1179-1187.
4. Lupini C, Cecchinato M, Scagliarini A, Graziani R, Catelli E: In vitro antiviral activity of chestnut and quebracho woods extracts against avian reovirus and metapneumovirus. Res Vet Sci 2009;87:482-487.
5. Funatogawa K, Hayashi S, Shimomura H, et al.: Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori. Microbiol Immunol 2004;48:251-261. (Pubitemid 38508665)
6. Quideau S, Varadinova T, Karagiozova D, et al.: Main structural and stereochemical aspects of the antiherpetic activity of non-ahydroxyterphenoyl- containing C-glycosidic ellagitannins. Chem Biodivers 2004;2:247-258.
7. Zuo GY, Li ZQ, Chen LR, Xu XJ: In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. Antivir Chem Chemother 2005;6:393-398.
8. Marzio L: Factors affecting gallbladder motility: drugs. Dig Liver Dis 2003;35 Suppl 3:S17-19. (Pubitemid 41070424)
9. Baker RA, Saccone GT, Costi D, Thune A, Toouli J: Motilin and erythromycin enhance the in vitro contractile activity of the sphincter of Oddi of the Australian brush-tailed possum. Naunyn Schmiedebergs Arch Pharmacol 1992;345:71-77.
10. Otto B, Mawe GM, Riepl RL: mu-Opiate receptor agonist lo-peramide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man. Neuro-gastroenterol Motil 2005;17:761-766. (Pubitemid 41400726)
11. Trendle MC, Moertel CG, Kvols LK: Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors. Cancer 1997;79:830-834. (Pubitemid 27076349)
12. Luo YL, Wang YL, Li NL, et al.: Actions of genistein on contractile response of smooth muscle isolated from guinea pig gallbladder. Hepatobiliary Pancreat Dis Int 2009;8:614-619.
13. Chuah SK, Wu KL, Tai WC, Changchien CS: The effects of ginger on gallbladder motility in healthy male humans. J Neu-rogastroenterol Motil 2011;17:411-415.
14. Luo YL, Zeng JW, Yu M, et al.: Effect of rhubarb on contractile response of gallbladder smooth muscle strips isolated from guinea pigs. World J Gastroenterol 2005;11:863-866. (Pubitemid 40298089)
15. Jin S, Li M, Lin ML, et al.: Effect of Fructus Psoraleae on motility of gallbladder isolated smooth muscle strips from guinea pigs. World J Gastroenterol 2006;12:5214-5218. (Pubitemid 44355921)
16. Rasyid A, Rahman AR, Jaalam K, Lelo A: Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr 2002;11:314-318. (Pubitemid 35464067)
17. Tierney S, Pitt HA, Lillemoe KD. Physiology and pathophysi-ology of gallbladder motility. Surg Clin North Am 1993;73: 1267-1290.
18. Venneman NG, van Erpecum KJ: Pathogenesis of gallstones. Gastroenterol Clin North Am 2010;39:171-183, vii.
19. Greaves RSH, O'Donnell LDJ: (2000) Gallbladder motility and gallstones. In: Afdhal NH, editor. Gallbladder and Biliary Tract Diseases. New York, NY:Marcel Dekker Inc. pp. 275-295.
20. Poston GJ, Draviam EJ, Yao CZ, et al.: The effect of age and cholecystokinin on gallstone formation in guinea pig. Gastro-enterology 1987;92:1765(A).
21. deOgburn R, Leite JO, Ratliff J, et al.: Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs. Comp Med 2012; 2: 109-115.
22. Van Rossum JM: Cumulative Dose-Response Curves. II. Technique for the making of Dose-Response Curves in Isolated Organs and the Evaluation of Drug Parameters. Arch Int Pharmacodyn 1963;143:299-330.
23. Gully D, Fréhel D, Marcy C, et al.: Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. Eur J Pharmacol 1993;232:13-19. (Pubitemid 23056991)
24. Moummi C, Gullikson GW, Gaginella TS: Monochloramine induces contraction of guinea pig gallbladder via two different pathways. Am J Physiol 1991;260:G881-886.
25. Motulsky H, Christopoulos A: (2003) Fitting Models to Biological Data Using Linear and Non Linear Regression, GraphPad, La Jolla, CA, 2003. Available: www.graphpad.com/manual/Prism4/RegressionBook.pdf.Accessed 2010 May 10.
26. Arunlakshana D, Schild HO: Some Quantitative Uses of Drug Antagonists. Br J Pharmacol 1959;14:48-58.
27. Tallarida RJ, Murray RB: (1987) Manual of Pharmacologic Calculations with Computer Programs, 2nd ed.; Springer-Verlag: New York.
28. Sanz M, Cadahía E, Esteruelas E, et al. Phenolic compounds in chestnut (Castanea sativa Mill.) heartwood. Effect of toasting at cooperage. J Agric Food Chem 2010;58:9631-9640.
29. Pasch. H.; Pizzi, A. Considerations on the macromolecular structure of chestnut ellagitannins by matrix-assisted laser desorption/ionization-time-of- flight mass spectrometry. J Appl Polym Sci 2002;85:429-437. (Pubitemid 34554926)
30. Masui H, Wakabayashi I: Preferential inhibition by ethanol of phorbol ester-induced smooth muscle contraction of guinea pig gallbladder. Life Sci 1998;62:673-678. (Pubitemid 28045574)
31. Grundy SM: Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 2004;80:1-2. (Pubitemid 41115546)
32. Nakeeb A, Comuzzie AG, Al-Azzawi H, et al.: Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg 2006; 10:940-948.
33. Van Erpecum KJ: Pathogenesis of cholesterol and pigment gallstones: an update. Clin Res Hepatol Gastroenterol 2011;35: 281-287.
34. Portincasa P, Moschetta A, Palasciano G: Cholesterol gallstone disease. Lancet 2006;368:230-239. (Pubitemid 44037798)
35. Caroli-Bosc FX, Le Gall P, Pugliese P, et al.: General Practitioners' Group of Vidauban, Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population. Dig Dis Sci 2001;46:540-544. (Pubitemid 32299807)
36. Portincasa P, Di Ciaula A, Vendemiale G, et al.: Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000;30: 317-324. (Pubitemid 30234860)
37. Portincasa P, DiCiaula AD, Bonfrate L, Wang DQ: Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012;6:7-20.
38. Shaffer EA Review article: control of gall-bladder motor function. Aliment Pharmacol Ther 2000;14 Suppl 2:2-8. (Pubitemid 30349072)
39. Stengel PW, Cohen ML: Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine- induced gallbladder contractility. J Pharmacol Exp Ther 2002;301:643-650. (Pubitemid 34429980)
40. Ioan P, Carosati E, Micucci M, Cruciani G, Broccatelli F, et al.: 1, 4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story so Far And Perspectives. (Part 1): Action in Ion Channels and GPCRs. Curr Med Chem 2011;18:4901-4922.
41. Carosati E, Ioan P, et al.: 1, 4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story so Far And Perspectives. (Part 2): Action in Other Targets and Antitargets. Curr Med Chem 2012;19:4306-4323.